The participation of activating transcription factor 6 alpha, ATF6α, in Alzheimer’s disease

Together, our results indicate that ATF6α may be differentially altered in AD. Further investigation of the ATF6α pathway in AD may offer a novel therapeutic perspective for cognitive decline.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.083626
Primary Topic
Nuclear Receptors and Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The participation of activating transcription factor 6 alpha, ATF6α, in Alzheimer’s disease

Mychael V. Lourenco, Mariana Gomes Chauvet, Alinny Rosendo Isaac
Alzheimer s & Dementia
Nuclear Receptors and Signaling
article

The participation of activating transcription factor 6 alpha, ATF6α, in Alzheimer’s disease

Mychael V. Lourenco, Mariana Gomes Chauvet, Alinny Rosendo Isaac
article en

Abstract

Together, our results indicate that ATF6α may be differentially altered in AD. Further investigation of the ATF6α pathway in AD may offer a novel therapeutic perspective for cognitive decline.

Alzheimer s & DementiaVol. 20(S1)
Universidade Federal do Rio de Janeiro (BR)
Openalex Percentile: Top 74%
Nuclear Receptors and Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The participation of activating transcription factor 6 alpha, ATF6α, in Alzheimer’s disease — Mychael V. Lourenco, Mariana Gomes Chauvet, et al. · Alzheimer s & Dementia (2024) | TGRS Research Map | TGRS